Stock VAISHALI VAISHALI PHARMA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Vaishali Pharma Limited

Equities

VAISHALI

INE972X01014

Pharmaceuticals

Delayed NSE India S.E.
Other stock markets
 05:14:46 2024-07-01 EDT 		5-day change 1st Jan Change
156.3 INR -0.30% Intraday chart for Vaishali Pharma Limited -5.20% -14.09%
05-30 Vaishali Pharma Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
02-02 Vaishali Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 282.2 286.7 422.4 343.8 697.6 1,539
Enterprise Value (EV) 1 464.1 455.2 590 519.2 894.1 1,681
P/E ratio 43.4 x 40.2 x 1,288 x 32.9 x 17.3 x 24.7 x
Yield - - - - - -
Capitalization / Revenue 0.42 x 0.38 x 0.7 x 0.64 x 0.92 x 2.21 x
EV / Revenue 0.68 x 0.61 x 0.98 x 0.97 x 1.18 x 2.41 x
EV / EBITDA 15.8 x 22.2 x 83.5 x 21.2 x 13.4 x 18.4 x
EV / FCF -3.89 x 66.6 x -33.8 x -26.3 x -24.6 x -50 x
FCF Yield -25.7% 1.5% -2.96% -3.8% -4.06% -2%
Price to Book 1.96 x 1.34 x 1.98 x 1.53 x 2.65 x 3.8 x
Nbr of stocks (in thousands) 7,385 10,546 10,546 10,546 10,546 10,546
Reference price 2 38.22 27.19 40.05 32.60 66.15 145.9
Announcement Date 18-09-04 19-09-06 20-09-02 21-09-02 22-09-08 23-05-22
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: März 2018 2019 2020 2021 2022 2023
Net sales 1 679.2 750.9 600.9 537.7 758.2 696.6
EBITDA 1 29.47 20.55 7.07 24.48 66.8 91.36
EBIT 1 26.98 17.89 4.628 22.21 64.29 88.74
Operating Margin 3.97% 2.38% 0.77% 4.13% 8.48% 12.74%
Earnings before Tax (EBT) 1 13.45 11.32 0.7911 14.05 57.28 88.46
Net income 1 7.976 7.136 0.3278 10.46 40.24 66.04
Net margin 1.17% 0.95% 0.05% 1.95% 5.31% 9.48%
EPS 2 0.8812 0.6766 0.0311 0.9921 3.815 5.910
Free Cash Flow 1 -119.4 6.831 -17.48 -19.75 -36.3 -33.61
FCF margin -17.58% 0.91% -2.91% -3.67% -4.79% -4.83%
FCF Conversion (EBITDA) - 33.24% - - - -
FCF Conversion (Net income) - 95.73% - - - -
Dividend per Share - - - - - -
Announcement Date 18-09-04 19-09-06 20-09-02 21-09-02 22-09-08 23-05-22
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: März 2018 2019 2020 2021 2022 2023
Net Debt 1 182 168 168 175 196 142
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 6.172 x 8.199 x 23.71 x 7.165 x 2.941 x 1.555 x
Free Cash Flow 1 -119 6.83 -17.5 -19.8 -36.3 -33.6
ROE (net income / shareholders' equity) 6.49% 3.4% 0.15% 4.78% 16.5% 19.7%
ROA (Net income/ Total Assets) 3.09% 1.68% 0.43% 1.82% 4.79% 6.91%
Assets 1 258.3 424.3 76.47 574 839.9 955.6
Book Value Per Share 2 19.50 20.30 20.30 21.30 25.00 38.40
Cash Flow per Share 2 0.2000 0.2200 0.2700 0.3000 1.100 0.5000
Capex 1 3.12 2.96 0.53 1.26 8.65 2.97
Capex / Sales 0.46% 0.39% 0.09% 0.23% 1.14% 0.43%
Announcement Date 18-09-04 19-09-06 20-09-02 21-09-02 22-09-08 23-05-22
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
VAISHALI PHARMA LIMITED Stock Vaishali Pharma Limited
-14.09% 20.16M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+55.32% 815B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+43.22% 641B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.75% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+13.56% 314B
ABBVIE INC. Stock AbbVie Inc.
+10.68% 303B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.00% 242B
ROCHE HOLDING AG Stock Roche Holding AG
+2.09% 224B
NOVARTIS AG Stock Novartis AG
+13.16% 218B
AMGEN INC. Stock Amgen Inc.
+8.48% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. VAISHALI Stock
  4. Financials Vaishali Pharma Limited